
Current Opinions on the Clinical Utility of Ravulizumab for the Treatment of Paroxysmal Nocturnal Hemoglobinuria
Author(s) -
Carmelo Gurnari,
Ishani Nautiyal,
Simona Pagliuca
Publication year - 2021
Publication title -
therapeutics and clinical risk management
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.719
H-Index - 55
eISSN - 1178-203X
pISSN - 1176-6336
DOI - 10.2147/tcrm.s273360
Subject(s) - eculizumab , paroxysmal nocturnal hemoglobinuria , medicine , cd59 , hemoglobinuria , complement system , immunology , hemolytic anemia , hemolysis , antibody